Business ยท National
Piramal Pharma to acquire remaining 26% stake in Yapan Bio
The drugmaker has exercised a call option, while acquisition consideration and the effective date of share transfer are yet to be finalised
Verified Timeline
No verified timeline updates.
What is your view on โPiramal Pharma to acquire remaining 26% stake in Yapan Bioโ?
This is self-selected reader participation, not representative scientific polling.

